Cite
HARVARD Citation
Mozessohn, L. et al. (2018). Azacitidine in the 'real‐world': an evaluation of 1101 higher‐risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, Canada. British journal of haematology. pp. 803-815. [Online].